The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Personalized dose monitoring of fluorouracil and metabolites of capecitabine (XELODA) in colorectal cancer patients (PersonaX).
 
Masato Nakamura
No Relationships to Disclose
 
Katsuya Makihara
No Relationships to Disclose
 
Toshihide Onikubo
No Relationships to Disclose
 
Kumi Nakamura
No Relationships to Disclose
 
Kazuya Uchibori
No Relationships to Disclose
 
Sayaka Azuma
No Relationships to Disclose
 
Kenta Murotani
No Relationships to Disclose
 
Shigeyoshi Iwamoto
No Relationships to Disclose
 
Hideyuki Mishima
Honoraria - Chugai Pharma; Takeda
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)